Watson Wants Lidoderm, Opana Pay-For-Delay Suits Split

By Eric Kroh (June 24, 2016, 1:05 PM EDT) -- Watson Laboratories Inc. and its owner Allergan PLC on Thursday asked a Pennsylvania federal court to sever the Federal Trade Commission's case claiming that it delayed generic competition for Lidoderm from another similar case over Opana ER, saying the agency was trying to merge two unrelated cases....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!